755030-94-5

Basic information

• Product Name: Benzonitrile, 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
• CAS NO: 755030-94-5
• Molecular Formula: C14H18BNO3
• Molecular Weight: 259.113
• Mol File: 755030-94-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(755030-94-5)
• EPA Substance Registry System: Benzonitrile, 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(755030-94-5)

Safety Data

• Hazardous Substances Data: 755030-94-5(Hazardous Substances Data)

Upstream product

• 677777-44-5 4-iodo-2-methoxybenzonitrile 
• 73183-34-3 bis(pinacol)diborane 
• 330793-38-9 4-bromo-2-methoxybenzonitrile 
• 1350933-21-9 2-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile 
• 74-88-4 methyl iodide 

Downstream Products

• 1308669-02-4 (S)-2-methoxy-4-[5-fluoro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-benzonitrile 
• 1308669-01-3 (R)-2-methoxy-4-[5-fluoro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-benzonitrile 
• 1308669-00-2 2-methoxy-4-[5-fluoro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-benzonitrile 
• 1308669-28-4 (S)-4-[5-chloro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308669-25-1 (R)-4-[5-chloro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308669-24-0 4-[5-chloro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308668-80-5 4-[4-(1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308668-83-8 4-[4-((S)-1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308668-81-6 4-[4-((R)-1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308670-06-5 4-(4-formylpyridin-3-yl)-2-methoxybenzonitrile 

Relevant articles and documents

N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to derivativesof formula (I) wherein (R1)n, R2, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description, to their preparation,

ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS

The present invention provides a compound of Formula (I); a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

BRIDGED, BICYCLIC HETEROCYCLIC OR SPIRO BICYCLIC HETEROCYCLIC DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF

Compounds of formula A: Formula (1) pharmaceutically acceptable salts thereof are described, which selectively inhibit Raf kinase activity and are useful for treating disorders mediated by Raf kinases.